Bank of New York Mellon’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Buy |
81,458
+3,311
|
|
||||
|
2025
Q1 | $206K | Buy |
78,147
+2,973
|
|
||||
|
2024
Q4 | $266K | Buy |
75,174
+6,051
|
|
||||
|
2024
Q3 | $315K | Sell |
69,123
-16,978
|
|
||||
|
2024
Q2 | $375K | Buy |
86,101
+11,269
|
|
||||
|
2024
Q1 | $376K | Sell |
74,832
-6,698
|
|
||||
|
2023
Q4 | $511K | Buy |
81,530
+6,674
|
|
||||
|
2023
Q3 | $533K | Sell |
74,856
-30,156
|
|
||||
|
2023
Q2 | $1.07M | Buy |
105,012
+68,827
|
|
||||
|
2023
Q1 | $328K | Buy |
36,185
+1,979
|
|
||||
|
2022
Q4 | $245K | Hold |
34,206
|
|
||||
|
2022
Q3 | $223K | Hold |
34,206
|
|
||||
|
2022
Q2 | $165K | Sell |
34,206
-397
|
|
||||
|
2022
Q1 | $196K | Sell |
34,603
-40
|
|
||||
|
2021
Q4 | $173K | Hold |
34,643
|
|
||||
|
2021
Q3 | $230K | Hold |
34,643
|
|
||||
|
2021
Q2 | $211K | Sell |
34,643
-12,034
|
|
||||
|
2021
Q1 | $310K | Sell |
46,677
-400
|
|
||||
|
2020
Q4 | $249K | Buy |
47,077
+32,639
|
|
||||
|
2020
Q3 | $107K | Hold |
14,438
|
|
||||
|
2020
Q2 | $106K | Buy |
+14,438
|
|
||||
|
2019
Q2 | – | Sell |
-20,068
|
|
||||
|
2019
Q1 | $60K | Sell |
20,068
-100
|
|
||||
|
2018
Q4 | $76K | Sell |
20,168
-40
|
|
||||
|
2018
Q3 | $119K | Buy |
20,208
+5,242
|
|
||||
|
2018
Q2 | $85K | Buy |
14,966
+441
|
|
||||
|
2018
Q1 | $180K | Sell |
14,525
-19,744
|
|
||||
|
2017
Q4 | $414K | Buy |
+34,269
|
|